{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T19:29:04Z","timestamp":1790710144523,"version":"4.1.0"},"reference-count":66,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2023,8,24]],"date-time":"2023-08-24T00:00:00Z","timestamp":1692835200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,8,24]],"date-time":"2023-08-24T00:00:00Z","timestamp":1692835200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82071410"],"award-info":[{"award-number":["82071410"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82001335"],"award-info":[{"award-number":["82001335"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100012165","name":"Key Technologies Research and Development Program","doi-asserted-by":"publisher","award":["2022YFC3501303"],"award-info":[{"award-number":["2022YFC3501303"]}],"id":[{"id":"10.13039\/501100012165","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100017950","name":"Shanghai Municipal Health Commission","doi-asserted-by":"publisher","award":["2018SHZDZX01"],"award-info":[{"award-number":["2018SHZDZX01"]}],"id":[{"id":"10.13039\/100017950","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Transl Med"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>\n                      Myasthenia gravis (MG) is the most prevalent autoimmune disorder affecting the neuromuscular junction. A rapid deterioration in respiratory muscle can lead to a myasthenic crisis (MC), which represents a life-threatening condition with high mortality in MG. Multiple CD4\n                      <jats:sup>+<\/jats:sup>\n                      T subsets and hypercytokinemia have been identified in the peripheral pro-inflammatory milieu during the crisis. However, the pathogenesis is complicated due to the many types of cells involved, leaving the underlying mechanism largely unexplored.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>We conducted single-cell transcriptomic and immune repertoire sequencing on 33,577 peripheral blood mononuclear cells (PBMCs) from two acetylcholine receptor antibody-positive (AChR\u2009+) MG patients during MC and again three months post-MC. We followed the Scanpy workflow for quality control, dimension reduction, and clustering of the single-cell data. Subsequently, we annotated high-resolution cell types utilizing transfer-learning models derived from publicly available single-cell immune datasets. RNA velocity calculations from unspliced and spliced mRNAs were applied to infer cellular state progression. We analyzed cell communication and MG-relevant cytokines and chemokines to identify potential inflammation initiators.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      We identified a unique subset of monocytes, termed monocytes 3 (FCGR3B\n                      <jats:sup>+<\/jats:sup>\n                      monocytes), which exhibited significant differential expression of pro-inflammatory signaling pathways during and after the crisis. In line with the activated innate immune state indicated by MC, a high neutrophil\u2013lymphocyte ratio (NLR) was confirmed in an additional 22 AChR\u2009+\u2009MC patients in subsequent hemogram analysis and was associated with MG-relevant clinical scores. Furthermore, oligoclonal expansions were identified in age-associated B cells exhibiting high autoimmune activity, and in CD4\n                      <jats:sup>+<\/jats:sup>\n                      and CD8\n                      <jats:sup>+<\/jats:sup>\n                      T cells demonstrating persistent T exhaustion.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>In summary, our integrated analysis of single-cell transcriptomics and TCR\/BCR sequencing has underscored the role of innate immune activation which is associated with hypercytokinemia in MC. The identification of a specific monocyte cluster that dominates the peripheral immune profile may provide some hints into the etiology and pathology of MC. However, future functional studies are required to explore causality.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s12967-023-04421-y","type":"journal-article","created":{"date-parts":[[2023,8,24]],"date-time":"2023-08-24T06:02:21Z","timestamp":1692856941000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":29,"title":["Peripheral immune landscape for hypercytokinemia in myasthenic crisis utilizing single-cell transcriptomics"],"prefix":"10.1186","volume":"21","author":[{"given":"Huahua","family":"Zhong","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiao","family":"Huan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rui","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manqiqige","family":"Su","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chong","family":"Yan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jie","family":"Song","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jianying","family":"Xi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chongbo","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Feifei","family":"Luo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9033-7568","authenticated-orcid":false,"given":"Sushan","family":"Luo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,8,24]]},"reference":[{"key":"4421_CR1","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1038\/s41572-019-0079-y","volume":"5","author":"NE Gilhus","year":"2019","unstructured":"Gilhus NE, Tzartos S, Evoli A, Palace J, Burns TM, Verschuuren JJGM. Myasthenia gravis. Nat Rev Dis Primers. 2019;5:30.","journal-title":"Nat Rev Dis Primers"},{"key":"4421_CR2","doi-asserted-by":"publisher","first-page":"419","DOI":"10.1212\/WNL.0000000000002790","volume":"87","author":"DB Sanders","year":"2016","unstructured":"Sanders DB, Wolfe GI, Benatar M, Evoli A, Gilhus NE, Illa I, et al. International consensus guidance for management of myasthenia gravis: executive summary. Neurology. 2016;87:419\u201325.","journal-title":"Neurology"},{"key":"4421_CR3","doi-asserted-by":"publisher","first-page":"516","DOI":"10.1186\/s12967-021-03185-7","volume":"19","author":"N Salari","year":"2021","unstructured":"Salari N, Fatahi B, Bartina Y, Kazeminia M, Fatahian R, Mohammadi P, et al. Global prevalence of myasthenia gravis and the effectiveness of common drugs in its treatment: a systematic review and meta-analysis. J Transl Med. 2021;19:516.","journal-title":"J Transl Med"},{"key":"4421_CR4","doi-asserted-by":"publisher","first-page":"822909","DOI":"10.3389\/fpubh.2022.822909","volume":"10","author":"V Ignatova","year":"2022","unstructured":"Ignatova V, Kostadinov K, Vassileva E, Muradyan N, Stefanov G, Iskrov G, et al. Socio-economic burden of myasthenia gravis: a cost-of-illness study in Bulgaria. Front Public Health. 2022;10:822909.","journal-title":"Front Public Health"},{"key":"4421_CR5","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1093\/qjmed\/hcn152","volume":"102","author":"A Chaudhuri","year":"2009","unstructured":"Chaudhuri A, Behan PO. Myasthenic crisis. QJM An Int J Med. 2009;102:97\u2013107.","journal-title":"QJM An Int J Med"},{"key":"4421_CR6","doi-asserted-by":"publisher","first-page":"e299","DOI":"10.1212\/WNL.0000000000008688","volume":"94","author":"B Neumann","year":"2020","unstructured":"Neumann B, Angstwurm K, Mergenthaler P, Kohler S, Sch\u00f6nenberger S, B\u00f6sel J, et al. Myasthenic crisis demanding mechanical ventilation: a multicenter analysis of 250 cases. Neurology. 2020;94:e299-313.","journal-title":"Neurology"},{"key":"4421_CR7","doi-asserted-by":"publisher","first-page":"797","DOI":"10.1002\/ana.22139","volume":"68","author":"A Mandawat","year":"2010","unstructured":"Mandawat A, Kaminski HJ, Cutter G, Katirji B, Alshekhlee A. Comparative analysis of therapeutic options used for myasthenia gravis. Ann Neurol. 2010;68:797\u2013805.","journal-title":"Ann Neurol"},{"key":"4421_CR8","doi-asserted-by":"publisher","first-page":"1548","DOI":"10.1212\/WNL.0b013e3181a41211","volume":"72","author":"A Alshekhlee","year":"2009","unstructured":"Alshekhlee A, Miles JD, Katirji B, Preston DC, Kaminski HJ. Incidence and mortality rates of myasthenia gravis and myasthenic crisis in US hospitals. Neurology. 2009;72:1548\u201354.","journal-title":"Neurology"},{"key":"4421_CR9","doi-asserted-by":"publisher","first-page":"3904","DOI":"10.1007\/s00415-022-11023-z","volume":"269","author":"P Mergenthaler","year":"2022","unstructured":"Mergenthaler P, Stetefeld HR, Dohmen C, Kohler S, Sch\u00f6nenberger S, B\u00f6sel J, et al. Seronegative myasthenic crisis: a multicenter analysis. J Neurol. 2022;269:3904\u201311.","journal-title":"J Neurol"},{"key":"4421_CR10","doi-asserted-by":"publisher","first-page":"30","DOI":"10.23736\/S0026-4784.20.04505-0","volume":"72","author":"MG Piccioni","year":"2020","unstructured":"Piccioni MG, Tabacco S, Giannini A, Deroma M, Logoteta A, Monti M. Myasthaenia gravis in pregnancy, delivery and newborn. Minerva Ginecol. 2020;72:30\u20135.","journal-title":"Minerva Ginecol"},{"key":"4421_CR11","doi-asserted-by":"publisher","first-page":"2075","DOI":"10.4049\/jimmunol.1501339","volume":"196","author":"Y Cao","year":"2016","unstructured":"Cao Y, Amezquita RA, Kleinstein SH, Stathopoulos P, Nowak RJ, O\u2019Connor KC. Autoreactive T cells from patients with myasthenia gravis are characterized by elevated IL-17, IFN-\u03b3, and GM-CSF and diminished IL-10 production. J Immunol. 2016;196:2075\u201384.","journal-title":"J Immunol"},{"key":"4421_CR12","doi-asserted-by":"publisher","first-page":"e945","DOI":"10.1212\/NXI.0000000000000945","volume":"8","author":"S Ashida","year":"2021","unstructured":"Ashida S, Ochi H, Hamatani M, Fujii C, Kimura K, Okada Y, et al. Immune skew of circulating follicular helper t cells associates with myasthenia gravis severity. Neurol Neuroimmunol Neuroinflamm. 2021;8:e945.","journal-title":"Neurol Neuroimmunol Neuroinflamm"},{"key":"4421_CR13","doi-asserted-by":"publisher","first-page":"1030","DOI":"10.1002\/mus.25162","volume":"54","author":"S-Y Kang","year":"2016","unstructured":"Kang S-Y, Kang C-H, Lee K-H. B-cell-activating factor is elevated in serum of patients with myasthenia gravis. Muscle Nerve. 2016;54:1030\u20133.","journal-title":"Muscle Nerve"},{"key":"4421_CR14","doi-asserted-by":"publisher","first-page":"367","DOI":"10.1007\/s40265-018-0875-9","volume":"78","author":"S Dhillon","year":"2018","unstructured":"Dhillon S. Eculizumab: a review in generalized myasthenia gravis. Drugs. 2018;78:367\u201376.","journal-title":"Drugs"},{"key":"4421_CR15","doi-asserted-by":"publisher","first-page":"749","DOI":"10.1002\/acn3.51312","volume":"8","author":"X Huan","year":"2021","unstructured":"Huan X, Luo S, Zhong H, Zheng X, Song J, Zhou L, et al. In-depth peripheral CD4+ T profile correlates with myasthenic crisis. Ann Clin Trans Neurol. 2021;8:749\u201362.","journal-title":"Ann Clin Trans Neurol"},{"key":"4421_CR16","doi-asserted-by":"publisher","first-page":"2255","DOI":"10.1056\/NEJMra2026131","volume":"383","author":"DC Fajgenbaum","year":"2020","unstructured":"Fajgenbaum DC, June CH. Cytokine storm. N Engl J Med. 2020;383:2255\u201373.","journal-title":"N Engl J Med"},{"key":"4421_CR17","doi-asserted-by":"publisher","first-page":"119","DOI":"10.3389\/fimmu.2019.00119","volume":"10","author":"CB Crayne","year":"2019","unstructured":"Crayne CB, Albeituni S, Nichols KE, Cron RQ. The immunology of macrophage activation syndrome. Front Immunol. 2019;10:119.","journal-title":"Front Immunol"},{"key":"4421_CR18","doi-asserted-by":"publisher","first-page":"109058","DOI":"10.1016\/j.clim.2022.109058","volume":"241","author":"Y Wang","year":"2022","unstructured":"Wang Y, Huan X, Jiao K, Jiang Q, Goh L-Y, Shi J, et al. Plasma exchange versus intravenous immunoglobulin in AChR subtype myasthenic crisis: a prospective cohort study. Clin Immunol. 2022;241:109058.","journal-title":"Clin Immunol"},{"key":"4421_CR19","doi-asserted-by":"publisher","first-page":"1407","DOI":"10.1007\/s42399-020-00438-2","volume":"2","author":"R Pourahmad","year":"2020","unstructured":"Pourahmad R, Moazzami B, Rezaei N. Efficacy of plasmapheresis and immunoglobulin replacement therapy (IVIG) on patients with COVID-19. SN Compr Clin Med. 2020;2:1407\u201311.","journal-title":"SN Compr Clin Med"},{"key":"4421_CR20","doi-asserted-by":"publisher","first-page":"486","DOI":"10.1016\/j.pulmoe.2020.10.017","volume":"27","author":"SM Hashemian","year":"2021","unstructured":"Hashemian SM, Shafigh N, Afzal G, Jamaati H, Tabarsi P, Marjani M, et al. Plasmapheresis reduces cytokine and immune cell levels in COVID-19 patients with acute respiratory distress syndrome (ARDS). Pulmonology. 2021;27:486\u201392.","journal-title":"Pulmonology"},{"key":"4421_CR21","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1016\/S1474-4422(21)00357-4","volume":"21","author":"MG Huijbers","year":"2022","unstructured":"Huijbers MG, Marx A, Plomp JJ, Panse RL, Phillips WD. Advances in the understanding of disease mechanisms of autoimmune neuromuscular junction disorders. Lancet Neurol. 2022;21:163\u201375.","journal-title":"Lancet Neurol"},{"key":"4421_CR22","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1038\/nri.2017.76","volume":"18","author":"E Papalexi","year":"2018","unstructured":"Papalexi E, Satija R. Single-cell RNA sequencing to explore immune cell heterogeneity. Nat Rev Immunol. 2018;18:35\u201345.","journal-title":"Nat Rev Immunol"},{"key":"4421_CR23","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41421-021-00314-w","volume":"7","author":"W Jin","year":"2021","unstructured":"Jin W, Yang Q, Peng Y, Yan C, Li Y, Luo Z, et al. Single-cell RNA-Seq reveals transcriptional heterogeneity and immune subtypes associated with disease activity in human myasthenia gravis. Cell Discov. 2021;7:1\u201318.","journal-title":"Cell Discov"},{"key":"4421_CR24","doi-asserted-by":"publisher","first-page":"114","DOI":"10.1212\/WNL.0000000000011124","volume":"96","author":"P Narayanaswami","year":"2021","unstructured":"Narayanaswami P, Sanders DB, Wolfe G, Benatar M, Cea G, Evoli A, et al. International consensus guidance for management of myasthenia gravis: 2020 update. Neurology. 2021;96:114\u201322.","journal-title":"Neurology"},{"key":"4421_CR25","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1186\/s13059-017-1382-0","volume":"19","author":"FA Wolf","year":"2018","unstructured":"Wolf FA, Angerer P, Theis FJ. SCANPY: large-scale single-cell gene expression data analysis. Genome Biol. 2018;19:15.","journal-title":"Genome Biol"},{"key":"4421_CR26","doi-asserted-by":"publisher","first-page":"1289","DOI":"10.1038\/s41592-019-0619-0","volume":"16","author":"I Korsunsky","year":"2019","unstructured":"Korsunsky I, Millard N, Fan J, Slowikowski K, Zhang F, Wei K, et al. Fast, sensitive and accurate integration of single-cell data with Harmony. Nat Methods. 2019;16:1289\u201396.","journal-title":"Nat Methods"},{"key":"4421_CR27","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1038\/s41587-021-01206-w","volume":"40","author":"A Gayoso","year":"2022","unstructured":"Gayoso A, Lopez R, Xing G, Boyeau P, Valiollah Pour Amiri V, Hong J, et al. A python library for probabilistic analysis of single-cell omics data. Nat Biotechnol. 2022;40:163\u20136.","journal-title":"Nat Biotechnol"},{"key":"4421_CR28","doi-asserted-by":"publisher","first-page":"1408","DOI":"10.1038\/s41587-020-0591-3","volume":"38","author":"V Bergen","year":"2020","unstructured":"Bergen V, Lange M, Peidli S, Wolf FA, Theis FJ. Generalizing RNA velocity to transient cell states through dynamical modeling. Nat Biotechnol. 2020;38:1408\u201314.","journal-title":"Nat Biotechnol"},{"key":"4421_CR29","doi-asserted-by":"publisher","first-page":"l5197","DOI":"10.1126\/science.abl5197","volume":"376","author":"C Dom\u00ednguez Conde","year":"2022","unstructured":"Dom\u00ednguez Conde C, Xu C, Jarvis LB, Rainbow DB, Wells SB, Gomes T, et al. Cross-tissue immune cell analysis reveals tissue-specific features in humans. Science. 2022;376:l5197.","journal-title":"Science"},{"key":"4421_CR30","doi-asserted-by":"publisher","first-page":"4230","DOI":"10.1038\/s41467-022-31951-8","volume":"13","author":"Y Yasumizu","year":"2022","unstructured":"Yasumizu Y, Ohkura N, Murata H, Kinoshita M, Funaki S, Nojima S, et al. Myasthenia gravis-specific aberrant neuromuscular gene expression by medullary thymic epithelial cells in thymoma. Nat Commun. 2022;13:4230.","journal-title":"Nat Commun"},{"key":"4421_CR31","doi-asserted-by":"publisher","first-page":"4573","DOI":"10.1126\/science.aah4573","volume":"356","author":"A-C Villani","year":"2017","unstructured":"Villani A-C, Satija R, Reynolds G, Sarkizova S, Shekhar K, Fletcher J, et al. Single-cell RNA-seq reveals new types of human blood dendritic cells, monocytes, and progenitors. Science. 2017;356:4573.","journal-title":"Science"},{"key":"4421_CR32","doi-asserted-by":"publisher","first-page":"D721","DOI":"10.1093\/nar\/gky900","volume":"47","author":"X Zhang","year":"2019","unstructured":"Zhang X, Lan Y, Xu J, Quan F, Zhao E, Deng C, et al. Cell marker: a manually curated resource of cell markers in human and mouse. Nucleic Acids Res. 2019;47:D721\u20138.","journal-title":"Nucleic Acids Res"},{"key":"4421_CR33","doi-asserted-by":"publisher","first-page":"523","DOI":"10.1093\/bioinformatics\/btt703","volume":"30","author":"A Kr\u00e4mer","year":"2014","unstructured":"Kr\u00e4mer A, Green J, Pollard J Jr, Tugendreich S. Causal analysis approaches in ingenuity pathway analysis. Bioinformatics. 2014;30:523\u201330.","journal-title":"Bioinformatics"},{"key":"4421_CR34","doi-asserted-by":"publisher","first-page":"D419","DOI":"10.1093\/nar\/gky1038","volume":"47","author":"H Mi","year":"2019","unstructured":"Mi H, Muruganujan A, Ebert D, Huang X, Thomas PD. PANTHER version 14: more genomes, a new PANTHER GO-slim and improvements in enrichment analysis tools. Nucleic Acids Res. 2019;47:D419\u201326.","journal-title":"Nucleic Acids Res"},{"key":"4421_CR35","doi-asserted-by":"publisher","first-page":"D457","DOI":"10.1093\/nar\/gkv1070","volume":"44","author":"M Kanehisa","year":"2016","unstructured":"Kanehisa M, Sato Y, Kawashima M, Furumichi M, Tanabe M. KEGG as a reference resource for gene and protein annotation. Nucleic Acids Res. 2016;44:D457\u201362.","journal-title":"Nucleic Acids Res"},{"key":"4421_CR36","doi-asserted-by":"publisher","first-page":"D613","DOI":"10.1093\/nar\/gkaa1024","volume":"49","author":"M Martens","year":"2021","unstructured":"Martens M, Ammar A, Riutta A, Waagmeester A, Slenter DN, Hanspers K, et al. WikiPathways: connecting communities. Nucleic Acids Res. 2021;49:D613\u201321.","journal-title":"Nucleic Acids Res"},{"key":"4421_CR37","doi-asserted-by":"publisher","first-page":"1088","DOI":"10.1038\/s41467-021-21246-9","volume":"12","author":"S Jin","year":"2021","unstructured":"Jin S, Guerrero-Juarez CF, Zhang L, Chang I, Ramos R, Kuan C-H, et al. Inference and analysis of cell-cell communication using cell chat. Nat Commun. 2021;12:1088.","journal-title":"Nat Commun"},{"key":"4421_CR38","doi-asserted-by":"publisher","first-page":"e13219","DOI":"10.1111\/acel.13219","volume":"19","author":"BM Hall","year":"2020","unstructured":"Hall BM, Gleiberman AS, Strom E, Krasnov PA, Frescas D, Vujcic S, et al. Immune checkpoint protein VSIG4 as a biomarker of aging in murine adipose tissue. Aging Cell. 2020;19:e13219.","journal-title":"Aging Cell"},{"key":"4421_CR39","doi-asserted-by":"publisher","DOI":"10.1136\/rmdopen-2021-001934","author":"M G","year":"2022","unstructured":"G M, von S SL, U A, K J, Z-P L, U N, et al. SIGLEC1 enables straightforward assessment of type I interferon activity in idiopathic inflammatory myopathies. RMD Open. 2022. https:\/\/doi.org\/10.1136\/rmdopen-2021-001934.","journal-title":"RMD Open"},{"key":"4421_CR40","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1111\/j.0022-202X.2005.23673.x","volume":"125","author":"RD Sontheimer","year":"2005","unstructured":"Sontheimer RD, Racila E, Racila DM. C1q: its functions within the innate and adaptive immune responses and its role in lupus autoimmunity. J Investig Dermatol. 2005;125:14\u201323.","journal-title":"J Investig Dermatol"},{"key":"4421_CR41","doi-asserted-by":"publisher","first-page":"76099","DOI":"10.18632\/oncotarget.18546","volume":"8","author":"D-H Yang","year":"2017","unstructured":"Yang D-H, Qian M-Z, Wei M-M, Li J, Yu M-M, Lu X-M, et al. The correlation of neutrophil-to-lymphocyte ratio with the presence and activity of myasthenia gravis. Oncotarget. 2017;8:76099\u2013107.","journal-title":"Oncotarget"},{"key":"4421_CR42","doi-asserted-by":"publisher","first-page":"388","DOI":"10.1186\/s12883-021-02412-4","volume":"21","author":"C-W Hsu","year":"2021","unstructured":"Hsu C-W, Chen N-C, Huang W-C, Lin H-C, Tsai W-C, Huang C-C, et al. Hemogram parameters can predict in-hospital mortality of patients with Myasthenic crisis. BMC Neurol. 2021;21:388.","journal-title":"BMC Neurol"},{"key":"4421_CR43","doi-asserted-by":"publisher","first-page":"402","DOI":"10.1007\/s00018-022-04433-9","volume":"79","author":"IC Mouat","year":"2022","unstructured":"Mouat IC, Goldberg E, Horwitz MS. Age-associated B cells in autoimmune diseases. Cell Mol Life Sci. 2022;79:402.","journal-title":"Cell Mol Life Sci"},{"key":"4421_CR44","doi-asserted-by":"publisher","DOI":"10.3389\/fneur.2020.596382","author":"JLS Thomsen","year":"2020","unstructured":"Thomsen JLS, Andersen H. Outcome measures in clinical trials of patients with myasthenia gravis. Front Neurol. 2020. https:\/\/doi.org\/10.3389\/fneur.2020.596382.","journal-title":"Front Neurol"},{"key":"4421_CR45","doi-asserted-by":"publisher","first-page":"102789","DOI":"10.1016\/j.ebiom.2020.102789","volume":"55","author":"K Kuppalli","year":"2020","unstructured":"Kuppalli K, Rasmussen AL. A glimpse into the eye of the COVID-19 cytokine storm. EBioMedicine. 2020;55:102789.","journal-title":"EBioMedicine"},{"key":"4421_CR46","doi-asserted-by":"publisher","first-page":"250","DOI":"10.1002\/jmv.26232","volume":"93","author":"B Hu","year":"2021","unstructured":"Hu B, Huang S, Yin L. The cytokine storm and COVID-19. J Med Virol. 2021;93:250\u20136.","journal-title":"J Med Virol"},{"key":"4421_CR47","doi-asserted-by":"publisher","first-page":"2271","DOI":"10.1007\/s10072-021-05823-w","volume":"43","author":"CL Rodrigues","year":"2022","unstructured":"Rodrigues CL, de Freitas HC, Lima PRO, de Oliveira Junior PH, Fernandes JMA, D\u2019Almeida JAC, et al. Myasthenia gravis exacerbation and myasthenic crisis associated with COVID-19: case series and literature review. Neurol Sci. 2022;43:2271\u20136.","journal-title":"Neurol Sci"},{"key":"4421_CR48","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1186\/s41983-022-00516-3","volume":"58","author":"D Tugasworo","year":"2022","unstructured":"Tugasworo D, Kurnianto A, Retnaningsih Andhitara Y, Ardhini R, Budiman J. The relationship between myasthenia gravis and COVID-19: a systematic review. Egypt J Neurol Psychiatry Neurosurg. 2022;58:83.","journal-title":"Egypt J Neurol Psychiatry Neurosurg"},{"key":"4421_CR49","doi-asserted-by":"publisher","first-page":"152043","DOI":"10.1016\/j.semarthrit.2022.152043","volume":"55","author":"Y Chen","year":"2022","unstructured":"Chen Y, Hu Z, Cai S, Shen G, Zhong J, Dong L. Efficacy of plasma exchange on top of standard immunosuppressive therapy in adult autoimmune inflammatory rheumatic diseases-associated macrophage activation syndrome, a single center real-world analysis. Semin Arthritis Rheum. 2022;55:152043.","journal-title":"Semin Arthritis Rheum"},{"key":"4421_CR50","doi-asserted-by":"publisher","first-page":"218","DOI":"10.1016\/j.critrevonc.2013.03.010","volume":"88","author":"GJK Guthrie","year":"2013","unstructured":"Guthrie GJK, Charles KA, Roxburgh CSD, Horgan PG, McMillan DC, Clarke SJ. The systemic inflammation-based neutrophil\u2013lymphocyte ratio: experience in patients with cancer. Crit Rev Oncol Hematol. 2013;88:218\u201330.","journal-title":"Crit Rev Oncol Hematol"},{"key":"4421_CR51","doi-asserted-by":"publisher","first-page":"23002","DOI":"10.1038\/srep23002","volume":"6","author":"MJ Olnes","year":"2016","unstructured":"Olnes MJ, Kotliarov Y, Biancotto A, Cheung F, Chen J, Shi R, et al. Effects of systemically administered hydrocortisone on the human immunome. Sci Rep. 2016;6:23002.","journal-title":"Sci Rep"},{"key":"4421_CR52","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1186\/s12891-016-1135-3","volume":"17","author":"DL Fleishaker","year":"2016","unstructured":"Fleishaker DL, Mukherjee A, Whaley FS, Daniel S, Zeiher BG. Safety and pharmacodynamic dose response of short-term prednisone in healthy adult subjects: a dose ranging, randomized, placebo-controlled, crossover study. BMC Musculoskelet Disord. 2016;17:293.","journal-title":"BMC Musculoskelet Disord"},{"key":"4421_CR53","doi-asserted-by":"publisher","first-page":"1109","DOI":"10.1007\/s10072-014-1659-y","volume":"35","author":"J Kalita","year":"2014","unstructured":"Kalita J, Kohat AK, Misra UK. Predictors of outcome of myasthenic crisis. Neurol Sci. 2014;35:1109\u201314.","journal-title":"Neurol Sci"},{"key":"4421_CR54","doi-asserted-by":"publisher","first-page":"158","DOI":"10.1111\/j.1600-065X.2012.01146.x","volume":"249","author":"D Tang","year":"2012","unstructured":"Tang D, Kang R, Coyne CB, Zeh HJ, Lotze MT. PAMPs and DAMPs: signal 0s that spur autophagy and immunity. Immunol Rev. 2012;249:158\u201375.","journal-title":"Immunol Rev"},{"key":"4421_CR55","doi-asserted-by":"publisher","first-page":"901","DOI":"10.1007\/s00401-021-02299-y","volume":"141","author":"F Ingelfinger","year":"2021","unstructured":"Ingelfinger F, Krishnarajah S, Kramer M, Utz SG, Galli E, Lutz M, et al. Single-cell profiling of myasthenia gravis identifies a pathogenic T cell signature. Acta Neuropathol. 2021;141:901\u201315.","journal-title":"Acta Neuropathol"},{"key":"4421_CR56","doi-asserted-by":"publisher","first-page":"109184","DOI":"10.1016\/j.clim.2022.109184","volume":"245","author":"R Fan","year":"2022","unstructured":"Fan R, Que W, Liu Z, Zheng W, Guo X, Liu L, et al. Single-cell mapping reveals dysregulation of immune cell populations and VISTA+ monocytes in myasthenia gravis. Clin Immunol. 2022;245:109184.","journal-title":"Clin Immunol"},{"key":"4421_CR57","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1016\/j.jaut.2017.05.005","volume":"82","author":"S Mamrut","year":"2017","unstructured":"Mamrut S, Avidan N, Truffault F, Staun-Ram E, Sharshar T, Eymard B, et al. Methylome and transcriptome profiling in myasthenia gravis monozygotic twins. J Autoimmun. 2017;82:62\u201373.","journal-title":"J Autoimmun"},{"key":"4421_CR58","doi-asserted-by":"publisher","first-page":"1671","DOI":"10.1016\/j.cell.2021.02.029","volume":"184","author":"JL Schultze","year":"2021","unstructured":"Schultze JL, Aschenbrenner AC. COVID-19 and the human innate immune system. Cell. 2021;184:1671\u201392.","journal-title":"Cell"},{"key":"4421_CR59","doi-asserted-by":"publisher","first-page":"103030","DOI":"10.1016\/j.isci.2021.103030","volume":"24","author":"N Nassir","year":"2021","unstructured":"Nassir N, Tambi R, Bankapur A, Al Heialy S, Karuvantevida N, Khansaheb HH, et al. Single-cell transcriptome identifies FCGR3B upregulated subtype of alveolar macrophages in patients with critical COVID-19. iScience. 2021;24:103030.","journal-title":"iScience"},{"key":"4421_CR60","doi-asserted-by":"publisher","first-page":"3124","DOI":"10.3389\/fimmu.2018.03124","volume":"9","author":"LW Treffers","year":"2019","unstructured":"Treffers LW, van Houdt M, Bruggeman CW, Heineke MH, Zhao XW, van der Heijden J, et al. Fc\u03b3RIIIb restricts antibody-dependent destruction of cancer cells by human neutrophils. Front Immunol. 2019;9:3124.","journal-title":"Front Immunol"},{"key":"4421_CR61","doi-asserted-by":"publisher","DOI":"10.1002\/mus.27832","author":"B Claytor","year":"2023","unstructured":"Claytor B, Cho S-M, Li Y. Myasthenic crisis. Muscle Nerve. 2023. https:\/\/doi.org\/10.1002\/mus.27832.","journal-title":"Muscle Nerve"},{"key":"4421_CR62","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2018.02285","author":"CR Smulski","year":"2018","unstructured":"Smulski CR, Eibel H. BAFF and BAFF-receptor in B cell selection and survival. Front Immunol. 2018. https:\/\/doi.org\/10.3389\/fimmu.2018.02285.","journal-title":"Front Immunol"},{"key":"4421_CR63","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2022.752189","author":"Y Zhu","year":"2022","unstructured":"Zhu Y, Tang X, Xu Y, Wu S, Liu W, Geng L, et al. RNASE2 mediates age-associated B cell expansion through monocyte derived IL-10 in patients with systemic lupus erythematosus. Front Immunol. 2022. https:\/\/doi.org\/10.3389\/fimmu.2022.752189.","journal-title":"Front Immunol"},{"key":"4421_CR64","doi-asserted-by":"publisher","first-page":"612","DOI":"10.1038\/nature14468","volume":"523","author":"EF McKinney","year":"2015","unstructured":"McKinney EF, Lee JC, Jayne DRW, Lyons PA, Smith KGC. T-cell exhaustion, co-stimulation and clinical outcome in autoimmunity and infection. Nature. 2015;523:612\u20136.","journal-title":"Nature"},{"key":"4421_CR65","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2020.621931","author":"B Van Den Eeckhout","year":"2021","unstructured":"Van Den Eeckhout B, Tavernier J, Gerlo S. Interleukin-1 as innate mediator of T cell immunity. Front Immunol. 2021. https:\/\/doi.org\/10.3389\/fimmu.2020.621931.","journal-title":"Front Immunol"},{"key":"4421_CR66","doi-asserted-by":"publisher","first-page":"355","DOI":"10.1038\/s41577-020-0331-4","volume":"20","author":"M Merad","year":"2020","unstructured":"Merad M, Martin JC. Pathological inflammation in patients with COVID-19: a key role for monocytes and macrophages. Nat Rev Immunol. 2020;20:355\u201362.","journal-title":"Nat Rev Immunol"}],"container-title":["Journal of Translational Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12967-023-04421-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12967-023-04421-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12967-023-04421-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,11,19]],"date-time":"2023-11-19T11:26:37Z","timestamp":1700393197000},"score":1,"resource":{"primary":{"URL":"https:\/\/translational-medicine.biomedcentral.com\/articles\/10.1186\/s12967-023-04421-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,8,24]]},"references-count":66,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2023,12]]}},"alternative-id":["4421"],"URL":"https:\/\/doi.org\/10.1186\/s12967-023-04421-y","relation":{},"ISSN":["1479-5876"],"issn-type":[{"value":"1479-5876","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,8,24]]},"assertion":[{"value":"16 February 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 August 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 August 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was carried out in accordance with the Declaration of Helsinki. The study was reviewed and approved by the institutional review board of General Huashan hospital Fudan University (2020\u2013883).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Informed consent was obtained from each participant.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"564"}}